Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CRO
CRO
Charles River's revenue drops amid industry restructuring work
Revenue for the quarter was $1.01 billion, down from $1.03 billion in both last quarter and the third quarter of 2023.
Darren Incorvaia
Nov 6, 2024 3:29pm
Syneos Health changes up CEO again
Oct 9, 2024 12:26pm
PharmaLegacy snaps up preclinical CRO
Sep 16, 2024 3:50pm
Lilly sells and ships San Diego robot lab to UK-based company
Sep 13, 2024 12:45pm
Charles River lays off 3% of workforce in wake of Q2 revenue dip
Sep 12, 2024 5:10pm
European oncology org extends partnership with Medidata
Sep 11, 2024 3:55pm
